Αποτελέσματα Αναζήτησης
This web page provides updated recommendations on low-dose aspirin prophylaxis for pregnant individuals at high or moderate risk of preeclampsia based on the USPSTF guidance. It also outlines the risk factors, timing, and implementation considerations for low-dose aspirin use.
2 Ιουν 2020 · Recently, the Aspirin for Evidence-Based Preeclampsia Prevention trial has revealed that aspirin at a daily dosage of 150 mg, initiated before 16 weeks of gestational age, and given at night to a high-risk population, identified by a combined first trimester screening test, reduces the incidence of preterm preeclampsia by 62%.
Learn about the benefits and risks of low-dose aspirin (81 mg/day) for preventing preeclampsia in high-risk and moderate-risk pregnant women. Find out the recommendations, indications, and evidence from ACOG and other health care organizations.
1 Σεπ 2021 · Daily aspirin use in pregnancy for individuals at increased risk for preeclampsia consistently led to beneficial effects on perinatal mortality, preterm birth, fetal growth restriction, and preeclampsia diagnosis across a clinically heterogeneous set of trials.
13 Ιαν 2023 · The International Federation of Gynecology and Obstetrics initiative on preeclampsia recommends 150 mg of aspirin to be initiated at 11 to 14+6 week’s gestation and also proposes that 2 tablets of 81 mg is an acceptable alternative.
24 Ιουλ 2020 · The current review included evidence on the effectiveness of low-dose aspirin in preventing preeclampsia in pregnant persons at increased risk and in decreasing adverse maternal and perinatal health outcomes, as well as assessing the maternal and fetal harms of low-dose aspirin use during pregnancy.
28 Σεπ 2021 · There is evidence from randomized trials that for individuals at high risk of preeclampsia, daily low-dose aspirin during pregnancy is effective in preventing preeclampsia as well as bad health outcomes associated with it, such as preterm birth, SGA or IUGR, and perinatal mortality.
